首页> 外文OA文献 >Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2)

【2h】

Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2)

机译：在绝经前BRCA1 / BRCA2突变携带者进行预防性切除后，激素替代疗法似乎是安全的。对临床实践中遗传性癌症中“读者的信”的反应，2005，3（2）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jan Lubiński;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2) [J] . Jan Lubi?ski Hereditary cancer in clinical practice . 2005,第3期

机译：在绝经前BRCA1 / BRCA2突变携带者中进行预防性切除后，激素替代疗法似乎是安全的。《遗传实践中对读者的信》临床反应，2005，3（2）
2. Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis [J] . Marchetti C., De Felice F., Boccia S., Critical reviews in oncology/hematology . 2018,第期

机译：激素替代疗法在预防性风险降低的Salpingo-Oophorectomy和BRCA1和BRCA2突变载体中的乳腺癌风险：Meta分析
3. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. [J] . Rebbeck TR, Friebel T, Wagner T, Journal of Clinical Oncology . 2005,第31期

机译：PROSE研究小组：短期激素替代疗法对BRCA1和BRCA2突变携带者双侧预防性卵巢切除术后乳腺癌风险降低的影响。
4. Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the Letter to readers in Hereditary Cancer in Clinical Practice 2005 3 (2) [O] . Jan Lubiński 2005

机译：在绝经前BRCA1 / BRCA2突变携带者进行预防性切除后激素替代疗法似乎是安全的。对临床实践中遗传性癌症中读者的信的反应20053（2）
5. Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2) [O] . Lubiński, Jan 2005

机译：在绝经前BRCA1 / BRCA2突变携带者进行预防性切除后，激素替代疗法似乎是安全的。对临床实践中遗传性癌症中“读者的信”的反应，2005，3（2）

Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2)

著录项

相似文献

相关主题

期刊订阅